Quiero saber acerca de...

jbell on DSKJLSW7X2PROD with RULES

948

Federal Register / Vol. 86, No. 4 / Thursday, January 7, 2021 / Rules and Regulations
List of Items Controlled Related Controls: 1 Certain forms of ricin and saxitoxin in 1C351.d.11. and d.12 are CWC Schedule 1 chemicals see 742.18 of the EAR. The U.S. Government must provide advance notification and annual reports to the OPCW of all exports of Schedule 1 chemicals. See 745.1 of the EAR for notification procedures. See 22
CFR part 121, Category XIV and 121.7 for CWC Schedule 1 chemicals that are subject to the ITAR. 2 The Animal and Plant Health Inspection Service APHIS, U.S. Department of Agriculture, and the Centers for Disease Control and Prevention CDC, U.S. Department of Health and Human Services, maintain controls on the possession, use, and transfer within the United States of certain items controlled by this ECCN for APHIS, see 7 CFR 331.3b, 9 CFR 121.3b, and 9 CFR 121.4b; for CDC, see 42 CFR 73.3b and 42 CFR
73.4b. 3 See 22 CFR part 121, Category XIVb, for modified biological agents and biologically derived substances that are subject to the ITAR.
Related Definitions: For the purposes of this entry, immunotoxins are monoclonal antibodies linked to a toxin with the intention of destroying a specific target cell while leaving adjacent cells intact.
Items:
a. Viruses identified on the Australia Group AG List of Human and Animal Pathogens and Toxins for Export Control, as follows:
a.1. African horse sickness virus;
a.2. African swine fever virus;
a.3. Andes virus;
a.4. Avian influenza AI viruses identified as having high pathogenicity HP, as follows:
a.4.a. AI viruses that have an intravenous pathogenicity index IVPI in 6-week-old chickens greater than 1.2; or a.4.b. AI viruses that cause at least 75%
mortality in 4- to 8-week-old chickens infected intravenously.
Note: Avian influenza AI viruses of the H5 or H7 subtype that do not have either of the characteristics described in 1C351.a.4
specifically, 1C351.a.4.a or a.4.b should be sequenced to determine whether multiple basic amino acids are present at the cleavage site of the haemagglutinin molecule HA0. If the amino acid motif is similar to that observed for other HPAI isolates, then the isolate being tested should be considered as HPAI and the virus is controlled under 1C351.a.4.
a.5. Bluetongue virus;
a.6. Chapare virus;
a.7. Chikungunya virus;
a.8. Choclo virus;
a.9. Classical swine fever virus Hog cholera virus;
a.10. Crimean-Congo hemorrhagic fever virus;
a.11. Dobrava-Belgrade virus;
a.12. Eastern equine encephalitis virus;
a.13. Ebolavirus includes all members of the Ebolavirus genus;
a.14. Foot-and-mouth disease virus;
a.15. Goatpox virus;
a.16. Guanarito virus;
a.17. Hantaan virus;

VerDate Sep<11>2014

16:55 Jan 06, 2021

Jkt 253001

a.18. Hendra virus Equine morbillivirus;
a.19. Japanese encephalitis virus;
a.20. Junin virus;
a.21. Kyasanur Forest disease virus;
a.22. Laguna Negra virus;
a.23. Lassa virus;
a.24. Louping ill virus;
a.25. Lujo virus;
a.26. Lumpy skin disease virus;
a.27. Lymphocytic choriomeningitis virus;
a.28. Machupo virus;
a.29. Marburgvirus includes all members of the Marburgvirus genus;
a.30. Middle East respiratory syndromerelated coronavirus MERS-related coronavirus;
a.31. Monkeypox virus;
a.32. Murray Valley encephalitis virus;
a.33. Newcastle disease virus;
a.34. Nipah virus;
a.35. Omsk hemorrhagic fever virus;
a.36. Oropouche virus;
a.37. Peste-des-petits ruminants virus;
a.38. Porcine Teschovirus;
a.39. Powassan virus;
a.40. Rabies virus and all other members of the Lyssavirus genus;
a.41. Reconstructed 1918 influenza virus;
Technical Note: 1C351.a.41 includes reconstructed replication competent forms of the 1918 pandemic influenza virus containing any portion of the coding regions of all eight gene segments.
a.42. Rift Valley fever virus;
a.43. Rinderpest virus;
a.44. Rocio virus;
a.45. Sabia virus;
a.46. Seoul virus;
a.47. Severe acute respiratory syndromerelated coronavirus SARS-related coronavirus;
a.48. Sheeppox virus;
a.49. Sin Nombre virus;
a.50. St. Louis encephalitis virus;
a.51. Suid herpesvirus 1 Pseudorabies virus; Aujeszkys disease;
a.52. Swine vesicular disease virus;
a.53. Tick-borne encephalitis virus Far Eastern subtype, formerly known as Russian Spring-Summer encephalitis virussee 1C351.b.3 for Siberian subtype;
a.54. Variola virus;
a.55. Venezuelan equine encephalitis virus;
a.56. Vesicular stomatitis virus;
a.57. Western equine encephalitis virus; or a.58. Yellow fever virus.
b. Viruses identified on the APHIS/CDC
select agents lists see Related Controls paragraph 2 for this ECCN, but not identified on the Australia Group AG List of Human and Animal Pathogens and Toxins for Export Control, as follows:
b.1. Reserved;
b.2. Reserved; or b.3. Tick-borne encephalitis virus Siberian subtype, formerly West Siberian virussee 1C351.a.53 for Far Eastern subtype.
c. Bacteria identified on the Australia Group AG List of Human and Animal Pathogens and Toxins for Export Control, as follows:
c.1. Bacillus anthracis;
c.2. Brucella abortus;
c.3. Brucella melitensis;
c.4. Brucella suis;
c.5. Burkholderia mallei Pseudomonas mallei;

PO 00000

Frm 00016

Fmt 4700

Sfmt 4700

c.6. Burkholderia pseudomallei Pseudomonas pseudomallei;
c.7. Chlamydia psittaci Chlamydophila psittaci;
c.8. Clostriduim argentinense formerly known as Clostridium botulinum Type G, botulinum neurotoxin producing strains;
c.9. Clostridium baratii, botulinum neurotoxin producing strains;
c.10. Clostridium botulinum;
c.11. Clostridium butyricum, botulinum neurotoxin producing strains;
c.12. Clostridium perfringens, epsilon toxin producing types;
c.13. Coxiella burnetii;
c.14. Francisella tularensis;
c.15. Mycoplasma capricolum subspecies capripneumoniae strain F38;
c.16. Mycoplasma mycoides subspecies mycoides SC small colony a.k.a. contagious bovine pleuropneumonia;
c.17. Rickettsia prowazekii;
c.18. Salmonella enterica subspecies enterica serovar Typhi Salmonella typhi;
c.19. Shiga toxin producing Escherichia coli STEC of serogroups O26, O45, O103, O104, O111, O121, O145, O157, and other shiga toxin producing serogroups;
Note: Shiga toxin producing Escherichia coli STEC includes, inter alia, enterohaemorrhagic E. coli EHEC, verotoxin producing E. coli VTEC or verocytotoxin producing E. coli VTEC.
c.20. Shigella dysenteriae;
c.21. Vibrio cholerae; or c.22. Yersinia pestis.
d. Toxins identified on the Australia Group AG List of Human and Animal Pathogens and Toxins for Export Control, as follows, or their subunits:
d.1. Abrin;
d.2. Aflatoxins;
d.3. Botulinum toxins;
d.4. Cholera toxin;
d.5. Clostridium perfringens alpha, beta 1, beta 2, epsilon and iota toxins;
d.6. Conotoxins;
d.7. Diacetoxyscirpenol;
d.8. HT-2 toxin;
d.9. Microcystins Cyanginosins;
d.10. Modeccin;
d.11. Ricin;
d.12. Saxitoxin;
d.13. Shiga toxins shiga-like toxins, verotoxins, and verocytotoxins;
d.14. Staphylococcus aureus enterotoxins, hemolysin alpha toxin, and toxic shock syndrome toxin formerly known as Staphylococcus enterotoxin F;
d.15. T-2 toxin;
d.16. Tetrodotoxin;
d.17. Viscumin Viscum album lectin 1; or d.18. Volkensin.
e. Fungi, as follows:
e.1. Coccidioides immitis; or e.2. Coccidioides posadasii.

5. In Supplement No. 1 to part 774, Category 1, ECCN 1C991 is revised to read as follows:

1C991 Vaccines, immunotoxins, medical products, diagnostic and food testing kits, as follows see List of Items Controlled.
License Requirements Reason for Control: CB, AT

E:FRFM07JAR1.SGM

07JAR1